Exelixis EXEL
NASDAQ EXEL
$59.02 -0.11 (-0.19%)
As of: Sep 4, 2026 · 3:59 PM EDT

Exelixis (EXEL) Amortization of Deferred Charges (2015 - 2017)

Exelixis (EXEL) posted quarterly Amortization of Deferred Charges of $93000.0 for Q2 2017, down 17.7% year-over-year from $113000.0 in Q2 2016, and up 4.49% quarter-over-quarter from $89000.0 in Q1 2017.

Analysis

Exelixis (EXEL) Amortization of Deferred Charges (2015 - 2017) Analysis & Trends

Exelixis' Amortization of Deferred Charges history runs 3 years deep, the most recent figure standing at $93000.0 for Q2 2017.

  • In Q2 2017, Amortization of Deferred Charges fell 17.7% year-over-year to $93000.0; the TTM figure through Jun 2018 stood at $93000.0 (up 101.68% YoY), while the FY2017 annual figure was $182000.0, down 97.84% from the prior year.
  • Amortization of Deferred Charges for Q2 2017 stood at $93000.0, up from $89000.0 in the prior quarter.
  • The five-year high for Amortization of Deferred Charges was $4.8 million in Q2 2015, with the low at -$5.8 million in Q4 2016.
  • The 3-year median for Amortization of Deferred Charges is $117000.0 (2016), against an average of $687125.0.
  • The sharpest annual moves came in 2016 and 2017: Amortization of Deferred Charges slumped 97.66% in 2016, then decreased 17.7% in 2017.
  • Exelixis' Amortization of Deferred Charges stood at $2.9 million in 2015, then sank by 299.45% to -$5.8 million in 2016, then surged by 101.59% to $93000.0 in 2017.
  • Business Quant data shows EXEL's Amortization of Deferred Charges at $93000.0 in Q2 2017, $89000.0 in Q1 2017, and -$5.8 million in Q4 2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Exelixis 14.81 Bn 13.97 Bn 608.03 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2017 93,000.00
Mar 31, 2017 89,000.00
Dec 30, 2016 137,000.00
Sep 30, 2016 121,000.00
Jun 30, 2016 113,000.00
Mar 31, 2016 3.16 Mn
Sep 30, 2015 2.93 Mn
Jun 30, 2015 4.83 Mn